Brett W. Wendling

Economist
Antitrust II
Phone:
(202) 326-2883
Email Address:
bwendling@ftc.gov

Selected Publications

  • "Economics at the FTC: Physician Acquisitions, Standard Essential Patents, and Accuracy of Credit Reporting," with Leemore Dafny, Beth Freeborn, and Julie Carlson, Review of Industrial Organization, forthcoming.
  • "Entry Threats and Pricing in the Generic Drug Industry," with Steven Tenn, Review of Economics and Statistics, forthcoming.
  • "Estimating the effect of entry on generic drug prices using Hatch-Waxman exclusivity," with Luke Olson, BE Working Paper, 2013.
  • "Informing the uninformed: How drug advertising affects check-up visits," with Daniel Hosken, International Journal of Industrial Organization, 2013.
  • "Economics at the FTC: Drug and PBM Mergers and Drip Pricing," with Howard Shelanski, Joseph Farrell, Christopher Metcalf, Daniel Hanner, and Mary Sullivan, Review of Industrial Organization, 2012.
  • "Authorized Generic Drugs: Short-Term Effects and Long-Term Impact," 2011.
  • "Economics at the FTC: Hospital Mergers, Authorized Generic Drugs, and Consumer Credit Markets," with Joseph Farrell, Keith Brand, and David Balan, Review of Industrial Organization, 2011.
  • "Authorized Generic Drugs: An Interim Report," 2009.
  • "The role of education in the production of health: an empirical analysis of smoking behavior," with Steven Tenn and Doug Herman Journal of Health Economics, 2008.
  • "The joint demand for cigarettes and marijuana: evidence from the National Household Surveys on Drug Abuse," with Matthew Farrelly, Gary Zarkin, and Jeremy Bray Journal of Health Economics, 2001.
  • "Healthcare use among women aged 45 and older: total costs and costs for selected post-menopausal health risks," with Thomas Hoerger, Richard Lindrooth, Downs, Lakshaman, Plouffe, West, and Ohsfeldt, Journal of Women's Health & Gender-Based Medicine, 1999.

Selected Presentations

  • "Estimating the effect of entry on generic drug prices using Hatch-Waxman exclusivity," IIOC. Boston, MA (2011)
  • "Entry Threats and Pricing in the Generic Drug Industry," IIOC. Boston, MA (2009)
  • "Informing the uninformed: How drug advertising affects check-up visits," FTC microeconomics conference. Washington, DC (2008)

Education

University of Texas - Austin
PhD Economics
2006
University of Texas - Austin
MA Economics
2003
Wake Forest University
BS Mathematical Economics
1997

Fields of Interest

  • Industrial Organization
  • Health Economics
  • Public Finance

Professional Experience

Economist
Federal Trade Commission
2006-present